[May 17, 2013] U.S. Patents Awarded to Inventors in New Jersey (May 17) Tweet (Targeted News Service Via Acquire Media NewsEdge) Targeted News Service Targeted News Service ALEXANDRIA, Va., May 17 -- The following federal patents were awarded to inventors in New Jersey. *** 3DMedia Assigned Patent ALEXANDRIA, Va., May 17 -- 3DMedia, Durham, N.C., has been assigned a patent (8,441,520) developed by four co-inventors for "primary and auxiliary image capture devcies for image processing and related methods." The co-inventors are Bahram Dahi, Chapel Hill, N.C., Michael McNamer, Apex, N.C., Izzat H. Izzat, Plainsboro, N.J., and Tassos Markas, Chapel Hill, N.C. The abstract of the patent published by the U.S. Patent and Trademark Office states: "Disclosed herein are primary and auxiliary image capture devices for image processing and related methods. According to an aspect, a method may include using primary and auxiliary image capture devices to perform image processing. The method may include using the primary image capture device to capture a first image of a scene, the first image having a first quality characteristic. Further, the method may include using the auxiliary image capture device to capture a second image of the scene. The second image may have a second quality characteristic. The second quality characteristic may be of lower quality than the first quality characteristic. The method may also include adjusting at least one parameter of one of the captured images to create a plurality of adjusted images for one of approximating and matching the first quality characteristic. Further, the method may include utilizing the adjusted images for image processing." The patent application was filed on Aug. 13, 2012 (13/584,744). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,441,520&OS=8,441,520&RS=8,441,520 Written by Satyaban Rath; edited by Hemanta Panigrahi. *** Veeco Instruments Assigned Patent ALEXANDRIA, Va., May 17 -- Veeco Instruments, Plainview, N.Y., has been assigned a patent (8,441,653) developed by four co-inventors for an "apparatus and method for batch non-contact material characterization." The co-inventors are Dong Seung Lee, Bridgewater, N.J., Mikhail Belousov, Plainsboro, N.J., Eric A. Armour, Pennington, N.J., and William E. Quinn, Whitehouse Station, N.J. The abstract of the patent published by the U.S. Patent and Trademark Office states: "An apparatus for performing non-contact material characterization includes a wafer carrier adapted to hold a plurality of substrates and a material characterization device, such as a device for performing photoluminescence spectroscopy. The apparatus is adapted to perform non-contact material characterization on at least a portion of the wafer carrier, including the substrates disposed thereon." The patent application was filed on June 13, 2012 (13/495,160). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,441,653&OS=8,441,653&RS=8,441,653 Written by Satyaban Rath; edited by Hemanta Panigrahi. *** Avaya Assigned Patent ALEXANDRIA, Va., May 17 -- Avaya, Basking Ridge, N.J., has been assigned a patent (8,442,202) developed by Sandra R. Abramson, Freehold, N.J., and Stephen M. Milton, Freehold, N.J., for a "private-branch exchange that provides outgoing calling for an off-premises terminal in the presence of a third-party application." The abstract of the patent published by the U.S. Patent and Trademark Office states: "A telecommunications system is disclosed that enables a user to pair a desk set that is an extension of a private-branch exchange with a cell phone that is accessible via the Public Switched Telephone Network. One feature of the telecommunications system enables a call that is directed to the user's desk set to be automatically forwarded to the user's cell phone. This is advantageous to the user because it provides the illusion to the caller that the user is physically in her office when she is not necessarily there. A similar feature also provides the illusion when a third party initiates a call that connects the user's cell phone to a called party. Such a third party includes a computer-telephony integration (CTI) application in a telephone telemarketing center, which automatically places many outgoing telephone calls." The patent application was filed on Feb. 5, 2007 (11/671,442). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,442,202&OS=8,442,202&RS=8,442,202 Written by Arpi Sharma; edited by Anand Kumar. *** Agere Systems Assigned Patent ALEXANDRIA, Va., May 17 -- Agere Systems, Allentown, Pa., has been assigned a patent (8,442,212) developed by four co-inventors for a "continuous power transfer scheme for two-wire serial link." The co-inventors are Johannes G. Ransijn, Wyomissing Hills, Pa., Boris A. Bark, Middletown, N.J., James D. Yoder, Leoa, Pa., and Peter Kiss, Basking Ridge, N.J. The abstract of the patent published by the U.S. Patent and Trademark Office states: "The invention provides a single digital communication link between system-side and line-side circuitry in a DAA, capable both of carrying data signals and of transferring a substantial amount of power to the line-side circuitry. The invention comprises a system-side interface circuit, a line-side interface circuit, and an isolation barrier including a transformer. Each interface circuit is capable of connection to an upstream communication circuit (either line-side or system-side), from which it may receive data signals to be transmitted across the isolation barrier to the other interface circuit, and to which it may pass data signals received across the isolation barrier from the other interface circuit. The line-side interface circuit may further include a rectifier and a storage device." The patent application was filed on April 28, 2011 (13/096,080). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,442,212&OS=8,442,212&RS=8,442,212 Written by Arpi Sharma; edited by Anand Kumar. *** Edda Technology Assigned Patent ALEXANDRIA, Va., May 17 -- Edda Technology, Princeton Junction, N.J., has been assigned a patent (8,442,280) developed by four co-inventors for a "method and system for intelligent qualitative and quantitative analysis of digital radiography softcopy reading." The co-inventors are Jianzhong Qian, Princeton Junction, N.J., Li Fan, Princeton Junction, N.J., Guo-Qing Wei, Princeton Junction, N.J., and Cheng-Chung Liang, Princeton Junction, N.J. The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present invention describes a method and system for intelligent diagnostic relevant information processing and analysis. Information associated with a patient is processed via an image reading platform. Based on such processed information, a matrix of diagnosis decisions containing diagnostic related information is generated via a matrix of diagnosis decision platform. A diagnostic decision is made based on the diagnostic relevant information. The image reading platform and/or the matrix of diagnosis decision platform encapsulate information and toolkits to be used to manipulate the information." The patent application was filed on Dec. 29, 2004 (11/024,033). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,442,280&OS=8,442,280&RS=8,442,280 Written by Arpi Sharma; edited by Anand Kumar. *** Analog Devices Assigned Patent ALEXANDRIA, Va., May 17 -- Analog Devices, Norwood, Mass., has been assigned a patent (8,442,174) developed by John Kenney, West Windsor, N.J., and Declan Dalton, Ballyneety, Ireland, for an "apparatus and method for rotational frequency detection." The abstract of the patent published by the U.S. Patent and Trademark Office states: "Apparatus and methods for rotational frequency detection are disclosed. In one embodiment, a rotational frequency detector is configured to receive samples taken from a serial data stream and to generate a frequency up error signal or a frequency down error signal. The rotational frequency detector processes a first set of samples to generate first transition data, which may be stored in a memory. The rotational frequency detector processes a second and third set of samples to generate second and third transition data. The frequency up or frequency down error signal is generated based at least partly on the first, second or third transition data. This configuration can reduce the maximum operating frequency of the rotational frequency detector, thereby simplifying the rotational frequency detector design to a point that a conventional static digital CMOS circuit design flow can be used to design the rotational frequency detector." The patent application was filed on Feb. 9, 2010 (12/703,056). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,442,174&OS=8,442,174&RS=8,442,174 Written by Arpi Sharma; edited by Anand Kumar. *** Futurewei Technologies Assigned Patent ALEXANDRIA, Va., May 17 -- Futurewei Technologies, Plano, Texas, has been assigned a patent (8,442,229) developed by Frank J. Effenberger, Freehold, N.J., for a "method and apparatus for providing security in a passive optical network." The abstract of the patent published by the U.S. Patent and Trademark Office states: "An apparatus and method for providing security in a Passive Optical Network (PON) using an Enhanced Security Control management entity (ME). In one embodiment, an optical network unit (ONU) comprising: a processor coupled to a memory and configured to exchange security information between the ONU and an optical line terminal (OLT) by using a plurality of attributes in an Enhanced Security Control management entity (ME) in the ONU via an ONU management control interface (OMCI) channel; wherein the plurality of attributes comprise: an OLT crypto capabilities attribute, an ONU selected crypto capabilities attribute, an OLT random challenge table attribute, an ONU authentication result table attribute, an ONU random challenge table attribute, an OLT authentication result table attribute, and a master session key name attribute." The patent application was filed on Nov. 14, 2011 (13/296,158). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,442,229&OS=8,442,229&RS=8,442,229 Written by Arpi Sharma; edited by Anand Kumar. *** University of Pennsylvania, University of New Jersey Assigned Patent ALEXANDRIA, Va., May 17 -- The University of Pennsylvania, Philadelphia, and the University of New Jersey, New Brunswick, N.J., have been assigned a patent (8,442,285) developed by four co-inventors for a "combined feature ensemble mutual information image registration." The co-inventors are Anant Madabhushi, South Plainfield, N.J., Jonathan Chappelow, Belle Mead, N.J., Michael Feldman, Garnet Valley, Pa., and John E. Tomaszewski, Abington, Pa. The abstract of the patent published by the U.S. Patent and Trademark Office states: "This invention relates to medical image registration. Specifically, the invention relates to a combined feature ensemble mutual information (COFEMI) for robust inter-modal, inter-protocol image registration." The patent application was filed on April 1, 2008 (12/593,651). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,442,285&OS=8,442,285&RS=8,442,285 Written by Arpi Sharma; edited by Anand Kumar. *** Analog Devices Assigned Patent for Apparatus and Method for Clock and Data Recovery ALEXANDRIA, Va., May 17 -- Analog Devices, Norwood, Mass., has been assigned a patent (8,442,173) developed by John Kenney, West Windsor, N.J., for an "apparatus and method for clock and data recovery." The abstract of the patent published by the U.S. Patent and Trademark Office states: "Apparatus and methods for clock and data recovery are disclosed. In one embodiment, a clock and data recovery system includes a sampler, a deserializer, a phase detector and a frequency detector. The sampler may be configured to sample a serial data stream to produce data samples and transition samples. The deserializer may be configured to deserialize the data samples and the transition samples to produce deserialized data samples and deserialized transition samples. The deserialized data samples and the deserialized transition samples can be aligned and provided to the phase detector and the frequency detector, thereby improving phase alignment and cycle slip detection." The patent application was filed on Feb. 9, 2010 (12/703,030). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,442,173&OS=8,442,173&RS=8,442,173 Written by Arpi Sharma; edited by Anand Kumar. *** Crestron Electronics Assigned Patent ALEXANDRIA, Va., May 17 -- Crestron Electronics, Rockledge, N.J., has been assigned a patent (8,442,215) developed by Daniel Jackson, Lyndhurst, N.J., Yun Mao, Paramus, N.J., and Robert Carter, New York, for "determining HDCP source KSV support." The abstract of the patent published by the U.S. Patent and Trademark Office states: "Presented is a method for determining the maximum number of key selection vectors (KSVs) supported by an HDCP source. The method includes providing a number of KSVs to the HDCP source, determining whether the HDCP source has entered a failure mode in response to the provided number of KSVs, increasing or decreasing the number of KSVs in response to the HDCP source not entering or entering the failure mode, providing the increased or decreased number of KSVs to the HDCP source, determining whether the HDCP source has entered the failure mode in response to the provided increased or decreased number of KSVs, and repeating the increasing, decreasing, and determining steps until the difference between a lowest number of provided KSVs resulting in the HDCP source entering the failure mode and a highest number of provided KSVs resulting in the HDCP source not entering the failure mode is one." The patent application was filed on July 9, 2010 (12/833,091). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,442,215&OS=8,442,215&RS=8,442,215 Written by Arpi Sharma; edited by Anand Kumar. *** Vidyo Assigned Patent ALEXANDRIA, Va., May 17 -- Vidyo, Hackensack, N.J., has been assigned a patent (8,442,120) developed by four co-inventors for a "system and method for thinning of scalable video coding bit-streams." The co-inventors are Danny Hong, New York, Thomas Wiegand, Berlin, Alexandros Eleftheriadis, New York, and Ofer Shapiro, Fair Lawn, N.J. The abstract of the patent published by the U.S. Patent and Trademark Office states: "A system for videoconferencing that offers, among other features, extremely low end-to-end delay as well as very high scalability. The system accommodates heterogeneous receivers and networks, as well as the best-effort nature of networks such as those based on the Internet Protocol. The system relies on scalable video coding to provide a coded representation of a source video signal at multiple temporal, quality, and spatial resolutions. These resolutions are represented by distinct bitstream components that are created at each end-user encoder. System architecture and processes called SVC Thinning allow the separation of data into data used for prediction in other pictures and data not used for prediction in other pictures. SVC Thinning processes, which can be performed at video conferencing endpoints or at MCUs, can selectively remove or replace with fewer bits the data not used for prediction in other pictures from transmitted bit streams. This separation and selective removal or replacement of data for transmission allows a trade-off between scalability support (i.e. number of decodable video resolutions), error resiliency and coding efficiency." The patent application was filed on Aug. 3, 2011 (13/197,352). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,442,120&OS=8,442,120&RS=8,442,120 Written by Arpi Sharma; edited by Anand Kumar. *** iBiquity Digital Assigned Patent ALEXANDRIA, Va., May 17 -- iBiquity Digital, Columbia, Md., has been assigned a patent (8,442,170) developed by Brian William Kroeger, Sykesville, Md., and Kun Wang, New Providence, N.J., for an "equalizer for AM in-band on-channel radio receivers." The abstract of the patent published by the U.S. Patent and Trademark Office states: "A method is provided for equalizing OFDM symbol vectors received on AM in-band on-channel radio signal including a main carrier and first and second BPSK modulated subcarriers. The method comprises the steps of: computing a BPSK magnitude signal; filtering the BPSK magnitude signal; filtering complex samples received on the main carrier; using the filtered BPSK magnitude signal and the filtered complex samples received on the main carrier to compute a plurality of flat fade equalization coefficients; and multiplying the OFDM symbol vectors by the flat fade equalization coefficients. A receiver that includes an equalizer, which operates in accordance with the method is also provided." The patent application was filed on Feb. 23, 2010 (12/710,534). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,442,170&OS=8,442,170&RS=8,442,170 Written by Arpi Sharma; edited by Anand Kumar. *** Avaya Assigned Patent for Connecting Wireless, Wireline, and Internet-protocol Terminals ALEXANDRIA, Va., May 17 -- Avaya, Basking Ridge, N.J., has been assigned a patent (8,442,192) developed by Parameshwaran Krishnan, Basking Ridge, N.J., and Jay M. Stiles, Watchung, N.J., for "connecting wireless, wireline, and internet-protocol terminals." The abstract of the patent published by the U.S. Patent and Trademark Office states: "An appliance for use at home or a business is disclosed that is inserted between the Public Switched Telephone Network and wireline terminal(s) in the home or business. The appliance also connects to the Internet and has a wireless transceiver for communicating with wireless terminals via radio. The appliance enables a user of a wireless terminal in the vicinity of the appliance to answer and conduct telephone calls on the wireline terminal(s) in the home or business. Furthermore, the appliance enables a user of the wireline terminal(s) in the home or business to initiate and conduct telephone calls through the wireless terminal. Furthermore, the appliance enables a user of the wireline terminal(s) in the home or business to answer, initiate, and conduct telephone calls through the Public Switched Telephone Network and the Internet." The patent application was filed on Aug. 25, 2008 (12/197,858). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,442,192&OS=8,442,192&RS=8,442,192 Written by Arpi Sharma; edited by Anand Kumar. *** Comcast Cable Communications Assigned Patent ALEXANDRIA, Va., May 17 -- Comcast Cable Communications, Philadelphia, has been assigned a patent (8,442,205) developed by six co-inventors for a "data and call routing and forwarding." The co-inventors are Arvind Kaushal, Marlton, N.J., Jon Boone, Coatesville, Pa., Sohel Khan, Philadelphia, Louis Rubin, Ruskin, Fla., Brett Sherman, Philadelphia, and Jaime Jimenez, Tinton Falls, N.J. The abstract of the patent published by the U.S. Patent and Trademark Office states: "One or more aspects of the disclosure relate to various functions and processes related to routing of calls originating from other service providers. For example, a method includes receiving a request to route a call or a call session, such as a session initiation request, from a second service provider and proceeding to route the requested call or session through a call routing facility of the first service provider to a requested destination of the call. Routing the call through the call routing facility may include determining a service provider type and/or an origination number type for the call, determining routing information for the call using the type information, and causing routing of the call to a destination of the call based on the routing information. Further aspects of the disclosure relate to various functions and processes related to accessing routing data and/or information from a routing database." The patent application was filed on Oct. 27, 2010 (12/913,634). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,442,205&OS=8,442,205&RS=8,442,205 Written by Arpi Sharma; edited by Anand Kumar. *** Ludwig Institute for Cancer Research Assigned Patent ALEXANDRIA, Va., May 17 -- Ludwig Institute for Cancer Research, New York, has been assigned a patent (8,440,807) developed by four co-inventors for an "A34 and A33-like 3 DNA protein, antibodies thereto and methods of treatment using same." The co-inventors are Matthew Scanlan, Princeton Junction, N.J., Gerd Ritter, New York, Lloyd Old, New York, and Achim Jungbluth, New York. The abstract of the patent published by the U.S. Patent and Trademark Office states: "Polynucleotide molecules and polypeptide molecules A34 and A33-like 3 are described, as well as antibodies to polypeptide molecules A34 and A33-like 3. Also described are methods of detecting cancers expressing these polypeptides, and methods and kits for diagnosing said cancers, and methods of inhibiting effects of a cancer in a patient." The patent application was filed on Sept. 15, 2011 (13/233,086). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=84,40,807.PN.&OS=PN/84,40,807&RS=PN/84,40,807 Written by Amal Ahmed; edited by Jaya Anand. *** Paratek Pharmaceuticals Assigned Patent ALEXANDRIA, Va., May 17 -- Paratek Pharmaceuticals, Boston, has been assigned a patent (8,440,646) developed by Michael N. Alekshun, Marlboro, N.J., and S. Ken Tanaka, Needham, Mass., for "substituted tetracycline compounds for treatment of Bacillus anthracis infections." The abstract of the patent published by the U.S. Patent and Trademark Office states: "Methods and compositions for the treatment of Bacillus anthracis infections are described." The patent application was filed on Oct. 10, 2007 (11/870,317). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=84,40,646.PN.&OS=PN/84,40,646&RS=PN/84,40,646 Written by Amal Ahmed; edited by Jaya Anand. *** Bayer HealthCare Assigned Patent ALEXANDRIA, Va., May 17 -- Bayer HealthCare, Tarrytown, N.Y., has been assigned a patent (8,441,363) developed by Igor Gofman, Croton-on-Hudson, N.Y., and Jun Chen, Warren, N.J., for a "rapid charging and power management of a battery-powered fluid analyte meter." The abstract of the patent published by the U.S. Patent and Trademark Office states: "A system and method is described for rapid charging and power management of a battery for a meter. A charger component is operably associated with the meter and is capable of executing a rapid charge algorithm for a rechargeable battery. The algorithm includes monitoring for a connection to an external power source and implementing a charging routine of a battery at a first charge rate and then at a second charge rate. The second charge rate is lower than the first charge rate. A temperature rise in the rechargeable battery due to the first charge rate has a negligible heat transfer effect on the fluid sample. The meter can also include a power switch for controlling current flow to a battery fuel gauge. The power switch is open when the meter enters into a sleep mode. The state of battery charge is determined after the meter exits the sleep mode." The patent application was filed on March 30, 2012 (13/436,416). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,441,363.PN.&OS=PN/8,441,363&RS=PN/8,441,363 Written by Kusum Sangma; edited by Anand Kumar. *** Univation Technologies Assigned Patent ALEXANDRIA, Va., May 17 -- Univation Technologies, Houston, has been assigned a patent (8,441,250) developed by Eric J. Markel, Kingwood, Texas, and Timothy R. Lynn, Glen Gardner, N.J., for a "method and apparatus for monitoring electrical properties of polymerization reactor wall film." The abstract of the patent published by the U.S. Patent and Trademark Office states: "Disclosed is a method for using at least one static probe during polymerization in a fluid bed polymerization reactor system to monitor a coating on a surface of the reactor system and a distal portion of each static probe, wherein the coating is exposed to flowing fluid within the reactor system during the reaction. The surface may be a reactor bed wall (exposed to the reactor's fluid bed) and the coating is exposed to flowing, bubbling fluid within the fluid bed during the reaction. The method may include steps of: during the polymerization reaction, operating the static probe to generate a sequence of data values ("high speed data") indicative of fluid flow variation (e.g., bubbling or turbulence), and determining from the high speed data at least one electrical property of the coating (e.g., of a portion of the coating on the distal portion of the static probe)." The patent application was filed on May 14, 2010 (12/780,088). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,441,250.PN.&OS=PN/8,441,250&RS=PN/8,441,250 Written by Kusum Sangma; edited by Anand Kumar. *** Merck Sharp & Dohme Assigned Patent ALEXANDRIA, Va., May 17 -- Merck Sharp & Dohme, Rahway, N.J., has been assigned a patent (8,440,702) developed by six co-inventors for "1,3-oxazolidin -2-one derivatives useful as CETP inhibitors." The co-inventors are Amjad Ali, Freehold, N.J., Zhijian Lu, Clinton, N.J., Peter J. Sinclair, Scotch Plains, N.J., Yi-Heng Chen, Whippany, N.J., Cameron J. Smith, Lawrenceville, N.J., and Hong Li, Edison, N.J. The abstract of the patent published by the U.S. Patent and Trademark Office states: "Compounds having the structure of Formula I, including pharmaceutically acceptable salts of the compounds, are CETP inhibitors, and are useful for raising HDL-cholesterol, reducing LDL-cholesterol, and for treating or preventing atherosclerosis. The compounds have 3 cyclic groups connected by single bonds, as for example triphenyl, which are attached directly to the ring of formula I or attached at the position B. ##STR00001##." The patent application was filed on March 28, 2011 (13/073,190). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=84,40,702.PN.&OS=PN/84,40,702&RS=PN/84,40,702 Written by Amal Ahmed; edited by Jaya Anand. *** Influmedix Assigned Patent ALEXANDRIA, Va., May 17 -- Influmedix, Radnor, Pa., has been assigned a patent (8,440,720) developed by Jizhou Wang, Eagleville, Pa., Xiaodong Fan, Center Valley, Pa., and Lidia Cristian, Princeton Junction, N.J., for "methods of use of antiviral compounds." The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present invention relates, in part, to methods of treatment, prevention, and inhibition of viral disorders. In one aspect, the present invention relates to inhibition of the M2 proton channel of influenza viruses (e.g. influenza A virus) and other similar viroporins (e.g., VP24 of Ebola and Marburg viruses; and NS3 protein of Bluetongue). The present invention further relates, inter alia, to compounds which have been shown to possess antiviral activity, in particular, inhibiting the M2 proton channel of influenza viruses." The patent application was filed on Sept. 13, 2010 (12/881,038). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=84,40,720.PN.&OS=PN/84,40,720&RS=PN/84,40,720 Written by Amal Ahmed; edited by Jaya Anand. *** Galderma Laboratories Assigned Patent ALEXANDRIA, Va., May 17 -- Galderma Laboratories, Fort Worth, Texas, has been assigned a patent (8,440,688) developed by Jack DeJovin, New Brunswick, N.J., and Isabelle Jean DeJovin, New Brunswick, N.J., for "compounds, formulations and methods for reducing skin wrinkles, creasing and sagging." The abstract of the patent published by the U.S. Patent and Trademark Office states: "Methods, compounds, and topical formulations for reduction of skin sagging, creasing and/or wrinkling are disclosed. The methods comprise topically applying a composition comprising an .alpha.2 adrenergic receptor agonist. Amelioration of skin sagging, creasing and/or wrinkling begins within minutes after topical application of a disclosed composition. A single application can significantly reduce skin sagging, creasing and/or wrinkling for at least about 8 hours." The patent application was filed on Aug. 2, 2011 (13/196,333). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=84,40,688.PN.&OS=PN/84,40,688&RS=PN/84,40,688 Written by Amal Ahmed; edited by Jaya Anand. *** Altera Assigned Patent ALEXANDRIA, Va., May 17 -- Altera, San Jose, Calif., has been assigned a patent (8,441,314) developed by Gregory Starr, San Jose, Calif., Kang Wei Lai, Milpitas, Calif., and Richard Y. Chang, Bloomfield, N.J., for a "configurable clock network for programmable logic device." The abstract of the patent published by the U.S. Patent and Trademark Office states: "In a programmable logic device having high-speed serial interface channels, a clock distribution network for providing one or more high-speed clocks to dynamic phase alignment circuitry of those high-speed serial interfaces includes at least one bus that is segmentable (e.g. using tristatable buffers). This allows the bus to be divided into different portions that can be connected to different clock sources when the high-speed serial interfaces are running at different speeds. In one embodiment, the segmenting elements (e.g., the aforementioned buffers) are located between selected channels (e.g., every fourth channel), limiting the size of the different segments. In another embodiment, segmenting elements are located between each channel, allowing complete user freedom in selecting the sizes of the segments. Thus, instead of providing a bus for every clock source, multiple clocks can be made available to different channels by segmenting a single bus." The patent application was filed on July 26, 2012 (13/558,904). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,441,314.PN.&OS=PN/8,441,314&RS=PN/8,441,314 Written by Kusum Sangma; edited by Anand Kumar. *** Yale University Assigned Patent ALEXANDRIA, Va., May 17 -- Yale University, New Haven, Conn., has been assigned a patent (8,440,810) developed by seven co-inventors for "riboswitches, methods for their use, and compositions for use with riboswitches." The co-inventors are Ronald R. Breaker, Guilford, Conn., Ali Nahvi, New Haven, Conn., Narasimhan Sudarsan, New Haven, Conn., Margaret S. Ebert, Hopewell, N.J., Wade Winkler, Dallas, Jeffrey E. Barrick, Lansing, Mich., and John K. Wickiser, Cornwall on Hudson, N.Y. The abstract of the patent published by the U.S. Patent and Trademark Office states: "It has been discovered that certain natural mRNAs serve as metabolite-sensitive genetic switches wherein the RNA directly binds a small organic molecule. This binding process changes the conformation of the mRNA, which causes a change in gene expression by a variety of different mechanisms. Modified versions of these natural "riboswitches" (created by using various nucleic acid engineering strategies) can be employed as designer genetic switches that are controlled by specific effector compounds. Such effector compounds that activate a riboswitch are referred to herein as trigger molecules. The natural switches are targets for antibiotics and other small molecule therapies. In addition, the architecture of riboswitches allows actual pieces of the natural switches to be used to construct new non-immunogenic genetic control elements, for example the aptamer (molecular recognition) domain can be swapped with other non-natural aptamers (or otherwise modified) such that the new recognition domain causes genetic modulation with user-defined effector compounds. The changed switches become part of a therapy regimen--turning on, or off, or regulating protein synthesis. Newly constructed genetic regulation networks can be applied in such areas as living biosensors, metabolic engineering of organisms, and in advanced forms of gene therapy treatments." The patent application was filed on Feb. 23, 2011 (13/033,174). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=84,40,810.PN.&OS=PN/84,40,810&RS=PN/84,40,810 Written by Amal Ahmed; edited by Jaya Anand. *** Saladax Biomedical Assigned Patent ALEXANDRIA, Va., May 17 -- Saladax Biomedical, Bethlehem, Pa., has been assigned a patent (8,440,796) developed by five co-inventors for "lenalidomide and thalidomide immunoassays." The co-inventors are Salvatore J. Salamone, Stockton, N.J., Jodi Blake Courtney, Doylestown, Pa., Alexander Volkov, Allentown, Pa., Howard Sard, Arlington, Mass., and Vishnumurthy Hegde, Chelmsford, Mass. The abstract of the patent published by the U.S. Patent and Trademark Office states: "Novel conjugates and immunogens derived from lenalidomide and antibodies generated by these immunogens are useful in immunoassays for the quantification and monitoring of thalidomide and lenalidomide in biological fluids." The patent application was filed on Nov. 23, 2011 (13/303,356). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=84,40,796.PN.&OS=PN/84,40,796&RS=PN/84,40,796 Written by Amal Ahmed; edited by Jaya Anand. *** Amira Pharmaceuticals Assigned Patent ALEXANDRIA, Va., May 17 -- Amira Pharmaceuticals, Princeton, N.J., has been assigned a patent (8,440,707) developed by six co-inventors for "antagonists of lysophosphatidic acid receptors." The co-inventors are John Howard Hutchinson, San Diego, Thomas Jon Seiders, San Diego, Bowei Wang, Westfield, N.J., Jeannie M. Arruda, San Diego, Jeffrey Roger Roppe, Temecula, Calif., and Timothy Parr, La Mesa, Calif. The abstract of the patent published by the U.S. Patent and Trademark Office states: "Described herein are compounds that are antagonists of lysophosphatidic receptor(s). Also described are pharmaceutical compositions and medicaments that include the compounds described herein, as well as methods of using such antagonists, alone and in combination with other compounds, for treating LPA-dependent or LPA-mediated conditions or diseases." The patent application was filed on April 22, 2011 (13/092,860). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=84,40,707.PN.&OS=PN/84,40,707&RS=PN/84,40,707 Written by Amal Ahmed; edited by Jaya Anand. *** Lexicon Pharmaceuticals Assigned Patent ALEXANDRIA, Va., May 17 -- Lexicon Pharmaceuticals, The Woodlands, Texas, has been assigned a patent (8,440,652) developed by ten co-inventors for "MST1 kinase inhibitors and methods of their use." The co-inventors are David John Augeri, Princeton, N.J., Jeffrey Thomas Bagdanoff, Martinez, Calif., Simon David Peter Baugh, Ringoes, N.J., Marianne Carlsen, Yardley, Pa., Kenneth Gordon Carson, Princeton, N.J., John Anthony Gilleran, Bridgewater, N.J., Wei He, Lawrenceville, N.J., Tamas Oravecz, The Woodlands, Texas, Konstantin Salojin, Conroe, Texas, and Leonard Sung, Hopewell, N.J. The abstract of the patent published by the U.S. Patent and Trademark Office states: "Compounds for the inhibition of mammalian Ste20-like kinase 1 (MST1) are disclosed, along with compositions comprising them and methods of their use in the treatment, management or prevention of an inflammatory or autoimmune diseases or disorders. Particular compounds are of the formula: ##STR00001##." The patent application was filed on March 2, 2012 (13/410,407). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=84,40,652.PN.&OS=PN/84,40,652&RS=PN/84,40,652 Written by Amal Ahmed; edited by Jaya Anand. *** Merck Sharp & Dohme Assigned Patent for Diphenyl Substituted Alkanes ALEXANDRIA, Va., May 17 -- Merck Sharp & Dohme, Rahway, N.J., has been assigned a patent (8,440,672) developed by eleven co-inventors for diphenyl substituted alkanes. The co-inventors are Anthony Ogawa, Mountainside, N.J., Feroze Ujjainwalla, Scotch Plains, N.J., Ellen K. Vande Bunte, Colts Neck, N.J., Lin Chu, Scotch Plains, N.J., Debra Ondeyka, Fanwood, N.J., Ihor Kopka, Hampton, N.J., Bing Li, Towaco, N.J., Hyun Ok, Colonia, N.J., Minal J. Patel, East Orange, N.J., Jinyou Xu, Scotch Plains, N.J., and Rosemary Sisco, Reading, Pa. The abstract of the patent published by the U.S. Patent and Trademark Office states: "The instant invention provides compounds of Formula I which are 5-lipoxygenase activating protein inhibitors. Compounds of Formula (I) are useful as anti-atherosclerotic, anti-asthmatic, anti-allergic, anti-inflammatory and cytoprotective agents. ##STR00001##." The patent application was filed on Aug. 29, 2007 (12/377,136). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=84,40,672.PN.&OS=PN/84,40,672&RS=PN/84,40,672 Written by Amal Ahmed; edited by Jaya Anand. *** Merck Sharp & Dohme Assigned Patent for Beta-amino Heterocyclic Dipeptidyl Peptidase Inhibitors for the Treatment of Type 2 Diabetes ALEXANDRIA, Va., May 17 -- Merck Sharp & Dohme, Rahway, N.J., has been assigned a patent (8,440,668) developed by seven co-inventors for "beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment of type 2 diabetes." The co-inventors are Scott D. Edmondson, Clark, N.J., Michael Fisher, Rahway, N.J., Dooseop Kim, Westfield, N.J., Malcolm MacCoss, Seabrook Island, S.C., Emma R. Parmee, Scotch Plains, N.J., Ann E. Weber, Scotch Plains, N.J., and Jinyou Xu, Scotch Plains, N.J. The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present invention is directed to compounds which are inhibitors of the dipeptidyl peptidase-IV enzyme ("DP-IV inhibitors") and which are useful in the treatment or prevention of diseases in which the dipeptidyl peptidase-IV enzyme is involved, such as diabetes and particularly type 2 diabetes. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which the dipeptidyl peptidase-IV enzyme is involved." The patent application was filed on April 14, 2011 (13/086,563). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=84,40,668.PN.&OS=PN/84,40,668&RS=PN/84,40,668 Written by Amal Ahmed; edited by Jaya Anand. *** Vitae Pharmaceuticals Assigned Patent ALEXANDRIA, Va., May 17 -- Vitae Pharmaceuticals, Fort Washington, Pa., has been assigned a patent (8,440,658) developed by nine co-inventors for "cyclic urea inhibitors of 11.beta.-hydroxysteroid dehydrogenase 1." The co-inventors are David A. Claremon, Maple Glen, Pa., Linghang Zhuang, Chalfont, Pa., Colin M. Tice, Ambler, Pa., Yuanjie Ye, Ambler, Pa., Wei He, Audubon, Pa., Suresh B. Singh, Kendall Park, N.J., Zhenrong Xu, Chalfont, Pa., Salvacion Cacatian, Conshohocken, Pa., and Wei Zhao, Eagleville, Pa. The abstract of the patent published by the U.S. Patent and Trademark Office states: "Disclosed is a compound represented by Formula (I): ##STR00001## or a pharmaceutically acceptable salt, monohydrate, enantiomer or diastereomer thereof. Also disclosed are pharmaceutical compositions comprising the compound of Formula (I) or a pharmaceutically acceptable salt, monohydrate, enantiomer or diastereomer thereof and methods of inhibiting 11.beta.-HSD1 activity comprising the step of administering to a mammal in need of such treatment an effective amount of a compound of Formula (I), or a pharmaceutically acceptable salt, monohydrate, enantiomer or diastereomer thereof. Values for the variables in Formula (I) are defined herein." The patent application was filed on Dec. 10, 2008 (12/747,391). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=84,40,658.PN.&OS=PN/84,40,658&RS=PN/84,40,658 Written by Amal Ahmed; edited by Jaya Anand. *** University of Southern Mississippi Assigned Patent ALEXANDRIA, Va., May 17 -- The University of Southern Mississippi, Hattiesburg, Miss., has been assigned a patent (8,440,736) developed by Charles E. Hoyle, Hattiesburg, Miss., Sergei Nazarenko, Hattiesburg, Miss., and Huanyu Wei, Fair Lawn, N.J., for "photocuable thiol-ene low gas permeability membranes." The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present invention provides modified multifunctional thiol-ene monomers wherein one or more thiols are reacted with a Michael addition reactive double bond compound. The present invention further discloses photocurable thiol-ene formulations comprising thiol-ene monomers including the modified multifunctional thiols. The present invention further discloses photocurable thiol-ene formulations comprising thiol-ene monomers and Michael addition reactive double bond molecules and a Michael catalyst. The formulations of the present invention can be photocured to make films or coatings. In a further disclosure, the formulations, including those comprised of unmodified multifunctional thiols and multifunctional enes, are photocured to form films applied to non-flexible or flexible polymer or non-polymer substrates suitable for food packaging, electronic products, optical products and other applications and free-standing films. The present invention further discloses photocurable thiol-ene formulations comprising thiol-ene monomers and Michael addition reactive double bond molecules and a Michael catalyst. These formulations are disclosed to form free-standing films and coatings on substrates when applied to flexible substrates. Such materials are suitable for use in the packaging of food products and other products which are to be maintained in a hermetically sealed relationship to the atmosphere." The patent application was filed on April 6, 2009 (12/419,013). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=84,40,736.PN.&OS=PN/84,40,736&RS=PN/84,40,736 Written by Amal Ahmed; edited by Jaya Anand. *** Hospital for Special Surgery, Princeton University, Texas A&M University System Assigned Patent ALEXANDRIA, Va., May 17 -- Hospital for Special Surgery, New York, Princeton University, Princeton, N.J., and Texas A&M University System, College Station, Texas, have been assigned a patent (8,440,618) developed by five co-inventors for a "composition for the attachment of implants to collagen or other components of biological tissue." The co-inventors are Suzanne A. Maher, Highland Lakes, N.J., Jeffrey Schwartz, Princeton, N.J., Axel Oscar Magnus Hook, Houston, Brooke Hageman Russell, Pearland, Texas, and Casey Marie Jones, Portland, Ore. The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present invention relates to a novel composition comprising an implant, scaffold or construct bound to a biological or chemical moiety. The bound moiety has the ability to bind to a component of the extracellular matrix of biological tissue, allowing the implant to be bound to the biological tissue in a short period of time after implantation. The invention also relates to the use and manufacture of this novel composition, as well as a novel use for the protein CNA." The patent application was filed on Jan. 19, 2012 (13/353,952). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=84,40,618.PN.&OS=PN/84,40,618&RS=PN/84,40,618 Written by Amal Ahmed; edited by Jaya Anand. For more information about Targeted News Service products and services, please contact: Myron Struck, editor, Targeted News Service LLC, Springfield, Va., 703/304-1897; [email protected]; http://targetednews.com. -1125259 (c) 2013 Targeted News Service [ Back To TMCnet.com's Homepage ]